Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Recommendation of “Moderate Buy” by Brokerages
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) has received an average rating of “Moderate Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price […]
More Stories
7 Best Delivery Apps to Make Money in 2025
In the current fast-paced world, side hustles have become an increasingly popular means of earning extra cash, specifically, food delivery...
NorthCrest Asset Manangement LLC Buys 4,007 Shares of Altria Group, Inc. (NYSE:MO)
NorthCrest Asset Manangement LLC increased its stake in shares of Altria Group, Inc. (NYSE:MO – Free Report) by 88.5% in...
CVA Family Office LLC Reduces Stake in Phillips 66 (NYSE:PSX)
CVA Family Office LLC decreased its stake in shares of Phillips 66 (NYSE:PSX – Free Report) by 11.4% during the...
NorthCrest Asset Manangement LLC Lowers Stock Holdings in U.S. Bancorp (NYSE:USB)
NorthCrest Asset Manangement LLC trimmed its stake in U.S. Bancorp (NYSE:USB – Free Report) by 7.0% in the 1st quarter,...
1,170 Shares in Marsh & McLennan Companies, Inc. (NYSE:MMC) Purchased by NorthCrest Asset Manangement LLC
NorthCrest Asset Manangement LLC acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report)...
Elevation Point Wealth Partners LLC Has $778,000 Stake in Adobe Inc. (NASDAQ:ADBE)
Elevation Point Wealth Partners LLC trimmed its stake in Adobe Inc. (NASDAQ:ADBE – Free Report) by 24.4% during the 1st...